BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 9676019)

  • 1. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
    Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
    Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
    Dissing M; Le Beau MM; Pedersen-Bjergaard J
    J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
    Bloomfield CD; Archer KJ; Mrózek K; Lillington DM; Kaneko Y; Head DR; Dal Cin P; Raimondi SC
    Genes Chromosomes Cancer; 2002 Apr; 33(4):362-78. PubMed ID: 11921271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
    Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
    Dassonneville L; Bailly C
    Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
    Arber DA; Slovak ML; Popplewell L; Bedell V; Ikle D; Rowley JD;
    Am J Clin Pathol; 2002 Feb; 117(2):306-13. PubMed ID: 11863228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study.
    Andersen MK; Christiansen DH; Pedersen-Bjergaard J
    Genes Chromosomes Cancer; 2005 Apr; 42(4):358-71. PubMed ID: 15645489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop.
    Slovak ML; Bedell V; Popplewell L; Arber DA; Schoch C; Slater R
    Genes Chromosomes Cancer; 2002 Apr; 33(4):379-94. PubMed ID: 11921272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
    Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related acute leukemia associated with involvement of 11q23 after high grade non-Hodgkin lymphoma.
    Martinelli G; Testoni N; Zinzani PL; Biondi A; Cimino G; Tura S
    Haematologica; 1998 Mar; 83(3):283-4. PubMed ID: 9573684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome.
    Nishiyama M; Arai Y; Tsunematsu Y; Kobayashi H; Asami K; Yabe M; Kato S; Oda M; Eguchi H; Ohki M; Kaneko Y
    Genes Chromosomes Cancer; 1999 Nov; 26(3):215-20. PubMed ID: 10502319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
    Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD
    Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
    Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
    Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations.
    Christiansen DH; Desta F; Andersen MK; Pedersen-Bjergaard J
    Genes Chromosomes Cancer; 2007 Jun; 46(6):517-21. PubMed ID: 17330262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and susceptibility to therapy-related myeloid neoplasms.
    Leone G; Fianchi L; Pagano L; Voso MT
    Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two different classes of therapy-related and de-novo acute myeloid leukemia?
    Pedersen-Bjergaard J; Philip P
    Cancer Genet Cytogenet; 1991 Aug; 55(1):119-24. PubMed ID: 1655239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.